Literature DB >> 31628947

Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.

Alexander Tischer1, Maria A Brehm2, Venkata R Machha1, Laurie Moon-Tasson1, Linda M Benson3, Katelynn J Nelton4, Rachel R Leger4, Tobias Obser2, Marina Martinez-Vargas5, Steven T Whitten6, Dong Chen7, Rajiv K Pruthi8, H Robert Bergen3, Miguel A Cruz5, Reinhard Schneppenheim2, Matthew Auton9.   

Abstract

Von Willebrand factor (VWF), an exceptionally large multimeric plasma glycoprotein, functions to initiate coagulation by agglutinating platelets in the blood stream to sites of vascular injury. This primary hemostatic function is perturbed in type 2 dysfunctional subtypes of von Willebrand disease (VWD) by mutations that alter the structure and function of the platelet GPIbα adhesive VWF A1 domains. The resulting amino acid substitutions cause local disorder and misfold the native structure of the isolated platelet GPIbα-adhesive A1 domain of VWF in both gain-of-function (type 2B) and loss-of-function (type 2M) phenotypes. These structural effects have not been explicitly observed in A1 domains of VWF multimers native to blood plasma. New mass spectrometry strategies are applied to resolve the structural effects of 2B and 2M mutations in VWF to verify the presence of A1 domain structural disorder in multimeric VWF harboring type 2 VWD mutations. Limited trypsinolysis mass spectrometry (LTMS) and hydrogen-deuterium exchange mass spectrometry (HXMS) are applied to wild-type and VWD variants of the single A1, A2, and A3 domains, an A1A2A3 tridomain fragment of VWF, plasmin-cleaved dimers of VWF, multimeric recombinant VWF, and normal VWF plasma concentrates. Comparatively, these methods show that mutations known to misfold the isolated A1 domain increase the rate of trypsinolysis and the extent of hydrogen-deuterium exchange in local secondary structures of A1 within multimeric VWF. VWD mutation effects are localized to the A1 domain without appreciably affecting the structure and dynamics of other VWF domains. The intrinsic dynamics of A1 observed in recombinant fragments of VWF are conserved in plasma-derived VWF. These studies reveal that structural disorder does occur in VWD variants of the A1 domain within multimeric VWF and provides strong support for VWF misfolding as a result of some, but not all, type 2 VWD variants.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hydrogen-deuterium exchange mass spectrometry; Limited proteolysis; Local disorder; Protein misfolding; von Willebrand factor

Mesh:

Substances:

Year:  2019        PMID: 31628947      PMCID: PMC7028320          DOI: 10.1016/j.jmb.2019.09.022

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  65 in total

1.  ExMS: data analysis for HX-MS experiments.

Authors:  Zhong-Yuan Kan; Leland Mayne; Palaniappan Sevugan Chetty; S Walter Englander
Journal:  J Am Soc Mass Spectrom       Date:  2011-09-15       Impact factor: 3.109

2.  N-terminal flanking region of A1 domain in von Willebrand factor stabilizes structure of A1A2A3 complex and modulates platelet activation under shear stress.

Authors:  Matthew Auton; Katie E Sowa; Molly Behymer; Miguel A Cruz
Journal:  J Biol Chem       Date:  2012-03-19       Impact factor: 5.157

Review 3.  The molecular biology of von Willebrand disease.

Authors:  S Keeney; A M Cumming
Journal:  Clin Lab Haematol       Date:  2001-08

4.  Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides.

Authors:  M A Cruz; H Yuan; J R Lee; R J Wise; R I Handin
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

5.  Conformational stability and domain unfolding of the Von Willebrand factor A domains.

Authors:  Matthew Auton; Miguel A Cruz; Joel Moake
Journal:  J Mol Biol       Date:  2006-10-25       Impact factor: 5.469

6.  Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction.

Authors:  Jan Schulte am Esch; Simon C Robson; Wolfram T Knoefel; Claus F Eisenberger; Matthias Peiper; Xavier Rogiers
Journal:  Br J Haematol       Date:  2005-01       Impact factor: 6.998

7.  Probing the high energy states in proteins by proteolysis.

Authors:  Chiwook Park; Susan Marqusee
Journal:  J Mol Biol       Date:  2004-11-05       Impact factor: 5.469

8.  Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate.

Authors:  Miguel A Cruz; Jody Whitelock; Jing-fei Dong
Journal:  Thromb Haemost       Date:  2003-12       Impact factor: 5.249

9.  N-linked glycan stabilization of the VWF A2 domain.

Authors:  Christopher J Lynch; David A Lane
Journal:  Blood       Date:  2016-01-14       Impact factor: 22.113

10.  O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions.

Authors:  Agata A Nowak; Kevin Canis; Anne Riddell; Michael A Laffan; Thomas A J McKinnon
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

View more
  2 in total

1.  Glycosylation sterically inhibits platelet adhesion to von Willebrand factor without altering intrinsic conformational dynamics.

Authors:  Alexander Tischer; Venkata R Machha; Laurie Moon-Tasson; Linda M Benson; Matthew Auton
Journal:  J Thromb Haemost       Date:  2019-09-03       Impact factor: 5.824

Review 2.  Advances in Hydrogen/Deuterium Exchange Mass Spectrometry and the Pursuit of Challenging Biological Systems.

Authors:  Ellie I James; Taylor A Murphree; Clint Vorauer; John R Engen; Miklos Guttman
Journal:  Chem Rev       Date:  2021-09-07       Impact factor: 72.087

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.